Compare Amazon.com Inc (AMZN) vs TG Therapeutics Inc (TGTX) Price & Performance

Amazon (AMZN) trades at $272.27, down 2.09% today, but maintains a bullish technical outlook with strong fundamental momentum. Revenue grew to $716.92 billion in 2025, with net income surging to $77.67 billion, and analysts project further growth to $775.7 billion in 2026. The stock shows robust cash flow generation and a consensus price target of $333.86, indicating significant upside potential from current levels.

Outlook is positive driven by AI investments and AWS growth, but risks include intense competition and high capital expenditures. With 89% analyst buy ratings and institutional confidence, AMZN offers long-term growth appeal, though volatility near resistance at $275 may present entry opportunities.

TG Therapeutics (TGTX) trades at $49.50, up 0.69% today, with a bearish technical signal from moving averages despite neutral oscillators. The company reported strong revenue growth, with Q2 2026 sales reaching $240 million and raised full-year guidance to $950 million, though it missed earnings estimates for three consecutive quarters. Profitability metrics remain robust with a net income margin of 55.22% and ROE exceeding 100%, but valuation ratios like EV/EBITDA at 56.26 suggest premium pricing.

The outlook is mixed: bullish analyst sentiment with an 84.6% buy rating and a $63.75 price target offers upside potential, driven by Briumvi's commercial success and expansion into schizophrenia trials. However, risks include earnings misses, a shareholder investigation into fiduciary duties, and high cash burn in 2025. Investors should weigh strong revenue momentum against execution risks and elevated valuations.